Saturday, October 31, 2026

Cohen & Steers Closed And 3 Other Stocks Have Very High Payout Ratio

Cohen & Steers Closed And 3 Other Stocks Have Very High Payout Ratio

(VIANEWS) - Cohen & Steers Closed (FOF), Sempra Energy (SRE), USD Partners LP (USDP) are the highest payout ratio stocks on this list.

We have collected information concerning stocks with the highest payout ratio up until now. The payout ratio in itself isn't a promise of good investment but it's an indicator of whether dividends are being paid and how the company chooses to issue them.

When researching a potential investment, the dividend payout ratio is a good statistic to know so here are a few stocks with an above 30% percent payout ratio.

1. Cohen & Steers Closed (FOF)

652.5% Payout Ratio

Cohen & Steers Closed-End Opportunity Fund, Inc. is a close-ended fund of funds launched by Cohen & Steers Inc. It is managed by Cohen & Steers Capital Management, Inc. The fund invests in funds investing in public equity markets.

Volume

Today's last reported volume for Cohen & Steers Closed is 52962 which is 27.84% below its average volume of 73396.

As claimed by Morningstar, Inc., the next dividend payment is on Aug 16, 2021, the estimated forward annual dividend rate is 1.04 and the estimated forward annual dividend yield is 7.1%.

Volatility

Cohen & Steers Closed's last day, week, and month's current volatility was 0.29%, 0.47%, and 0.80%, respectively.

Cohen & Steers Closed's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 0.72% (day), 1.01% (last week), and 1.23% (last month), respectively.

Cohen & Steers Closed's Stock Yearly Top and Bottom Value

Cohen & Steers Closed's stock is valued at $14.70 at 14:23 EST, below its 52-week high of $14.84 and way above its 52-week low of $10.06.

Cohen & Steers Closed's Moving Average

Cohen & Steers Closed's worth is higher than its 50-day moving average of $14.37 and above its 200-day moving average of $13.57.

2. Sempra Energy (SRE)

59.23% Payout Ratio

Sempra Energy operates as an energy-services holding company in the United States and internationally.

Volume

Today's last reported volume for Sempra Energy is 709207 which is 56.42% below its average volume of 1627360.

As stated by Morningstar, Inc., the next dividend payment is on Jul 5, 2021, the estimated forward annual dividend rate is 4.4 and the estimated forward annual dividend yield is 3.32%.

Sempra Energy's sales growth this year is expected to be 6.2% and 3.9% for next year.

Year-on-year quarterly revenue growth grew by 7.6%, now sitting on 11.6B for the twelve trailing months.

Sempra Energy's sales growth for the current quarter is 6.3%. The company's growth estimates for the ongoing quarter and the next is negative 1.2% and 24.4%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 9.7%.

Volatility

Sempra Energy's last day, week, and month's current volatility was 0.44%, 0.68%, and 0.98%, respectively.

Sempra Energy's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.27% (day), 1.35% (last week), and 1.65% (last month), respectively.

Sempra Energy's Stock Yearly Top and Bottom Value

Sempra Energy's stock is valued at $134.26 at 14:23 EST, below its 52-week high of $144.93 and way above its 52-week low of $112.33.

Sempra Energy's Moving Average

Sempra Energy's worth is under its 50-day moving average of $136.29 and higher than its 200-day moving average of $130.78.

3. USD Partners LP (USDP)

53.49% Payout Ratio

USD Partners LP acquires, develops, and operates midstream infrastructure assets and logistics solutions for crude oil, biofuels, and other energy-related products in the United States and Canada.

Volume

Today's last reported volume for USD Partners LP is 46860 which is 60% below its average volume of 117162.

According to Morningstar, Inc., the next dividend payment is on May 3, 2021, the estimated forward annual dividend rate is 0.45 and the estimated forward annual dividend yield is 6.05%.

USD Partners LP's sales growth this year is anticipated to be negative 4.7% and 25.3% for next year.

Year-on-year quarterly revenue growth grew by 2.9%, now sitting on 119.99M for the twelve trailing months.

USD Partners LP's sales growth is 15.6% for the ongoing quarter and negative 2.5% for the next. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 1315.32%.

Volatility

USD Partners LP's last day, week, and month's current volatility was 4.54%, 3.85%, and 2.23%, respectively.

USD Partners LP's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 7.56% (day), 5.36% (last week), and 3.60% (last month), respectively.

USD Partners LP's Stock Yearly Top and Bottom Value

USD Partners LP's stock is valued at $7.46 at 14:23 EST, below its 52-week high of $8.27 and way above its 52-week low of $2.60.

USD Partners LP's Moving Average

USD Partners LP's worth is above its 50-day moving average of $7.18 and way above its 200-day moving average of $5.70.

4. Trustmark Corporation (TRMK)

30.87% Payout Ratio

Trustmark Corporation operates as the bank holding company for Trustmark National Bank that provides banking and other financial solutions to individuals and corporate institutions in the United States.

Volume

Today's last reported volume for Trustmark Corporation is 209265 which is 6.04% above its average volume of 197350.

As claimed by Morningstar, Inc., the next dividend payment is on May 27, 2021, the estimated forward annual dividend rate is 0.92 and the estimated forward annual dividend yield is 2.93%.

Trustmark Corporation's sales growth this year is expected to be negative 8.4% and a negative 0.8% for next year.

Year-on-year quarterly revenue growth grew by 16.7%, now sitting on 689.8M for the twelve trailing months.

Trustmark Corporation's sales growth for the current quarter is 3.4%. The company's growth estimates for the current quarter and the next is 13.7% and negative -36%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 11.12%.

Volatility

Trustmark Corporation's last day, week, and month's current volatility was 1.43%, 0.89%, and 1.17%, respectively.

Trustmark Corporation's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.40% (day), 1.95% (last week), and 2.75% (last month), respectively.

Trustmark Corporation's Stock Yearly Top and Bottom Value

Trustmark Corporation's stock is valued at $30.67 at 14:23 EST, way below its 52-week high of $36.31 and way higher than its 52-week low of $20.08.

Trustmark Corporation's Moving Average

Trustmark Corporation's worth is below its 50-day moving average of $32.17 and below its 200-day moving average of $31.86.

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Catalyst Cluster: Ivonescimab's PDUFA Date and Small-Cap Biotech Delistings
ESMO 2026 (Oct 22-24) concentrates a wave of oncology readouts. Summit's ivonescimab (10 presentations, positive HARMONi-GI1 OS, new EA2251 Phase II/III with ECOG-ACRIN) leads, ahead of its FDA PDUFA date of 2026-11-14, and Daiichi Sankyo's DXd ADC platform (REJOICE-Ovarian, DESTINY-Lung04, TUXEDO-3) follows. At the other end of the capital-markets spectrum, micro-cap Spago Nanomedical is moving to delist from Nasdaq First North (board resolution Oct 22, EGM Nov 19, application Jan 2027). Pivotal data and regulatory milestones are rewarding well-funded late-stage players, while cash-constrained early-stage developers are exiting public markets.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,525 source documents archived
Query this data → isubstrate.com